Soluble Fas in serum from patients with renal cell carcinoma - a protein tyrosine phosphatase that associates with Fas

Author： Nonomura N. Nishimura K. Ono Y. Fukui T. Harada Y. Takaha N. Takahara S. Okuyama A.

Publisher： Elsevier

ISSN： 0090-4295

Source： Urology, Vol.55, Iss.1, 2000-01, pp. : 151-155

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Examination of soluble Fas (sFas) and soluble Fas ligand (sFasL) in patients with burns

By Yamada Y. Endo S. Nakae H. Makabe H. Sato N. Wakabayashi G. Kitamura M. Inada K. Sato S.

Burns, Vol. 29, Iss. 8, 2003-12 ,pp. : 799-802

Elsevier

Access to resources Recommend Favorite

Association of radionuclide bone scan and serum alkaline phosphatase in patients with metastatic renal cell carcinoma

By Seaman E. Goluboff E.T. Ross S. Sawczuk I.S.

Urology, Vol. 48, Iss. 5, 1996-11 ,pp. : 692-695

Elsevier

Access to resources Recommend Favorite

Increased intracellular doxorubicin by anti-Fas monoclonal antibody: a mechanism that enhances the cytotoxicity in renal cell carcinoma cells

By Wu X.-X. Kakehi Y. Mizutani Y. Terachi T. Ogawa O.

Urology, Vol. 57, Iss. 5, 2001-05 ,pp. : 993-998

Elsevier

Access to resources Recommend Favorite

Serum soluble fas ligand levels in familial Mediterranean fever

By Ceri Mevlut Unverdi Selman Senes Mehmet Altay Mustafa Yilmaz Rahmi Yucel Dogan Duranay Murat

Renal Failure, Vol. 35, Iss. 6, 2013-07 ,pp. : 835-837

Informa Healthcare

Access to resources Recommend Favorite

Serum Levels of Soluble Interleukin-2 Receptor in Renal Cell Carcinoma

By Matsumoto T. Furukawa A. Sumiyoshi Y. Akiyama K.-y. Kanayama H.-o. Kagawa S.

Urology, Vol. 51, Iss. 1, 1998-01 ,pp. : 145-149

Elsevier

Access to resources Recommend Favorite